Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 0.46 |
| ▸ | TAS2R14 | Q9NYV8 | 4/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | BMP1 | P13497 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27192066 | 1.00 | CNR2 (0.46) | CNR2TAS2R14CNR1BMP1LMNA | |
| SCHEMBL30609120 | 0.90 | CNR2 (0.43) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL29407317 | 0.90 | CNR2 (0.43) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL30701970 | 0.90 | CNR2 (0.50) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL1571343 | 0.90 | CNR2 (0.43) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL1411474 | 0.90 | CNR2 (0.50) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL1705734 | 0.89 | CNR2 (0.44) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL12205672 | 0.87 | CNR2 (0.56) | CNR2TAS2R14CNR1 | |
| SCHEMBL7952809 | 0.87 | CNR2 (0.42) | CNR2TAS2R14CNR1LMNATSHR | |
| SCHEMBL1705206 | 0.86 | CNR2 (0.60) | CNR2TAS2R14CNR1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565574-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2025-06-11 | — | — | EP | disclosed |
| CN-119731159-A | SARS-CoV2 main proteinase inhibitor | 吉利德科学公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024031089-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2024-02-08 | — | — | WO | disclosed |